Does NITROGLYCERIN Cause Mobility decreased? 543 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 543 reports of Mobility decreased have been filed in association with NITROGLYCERIN (Glonoinum). This represents 7.3% of all adverse event reports for NITROGLYCERIN.
543
Reports of Mobility decreased with NITROGLYCERIN
7.3%
of all NITROGLYCERIN reports
0
Deaths
534
Hospitalizations
How Dangerous Is Mobility decreased From NITROGLYCERIN?
Of the 543 reports, 534 (98.3%) required hospitalization, and 73 (13.4%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 543 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which NITROGLYCERIN Alternatives Have Lower Mobility decreased Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE